Generare Bioscience unlocks nature’s untapped potential by translating microbial DNA complexity into a scalable platform for discovering natural bioactive molecules. Their approach combines cutting-edge biotechnology and data to accelerate identification of new compounds with potential medical and broader applications. The company emphasizes high-throughput cloning to reveal bioactive molecules at speed and scale, with a focus on first-in-class medicines, including antibiotics and cancer therapies, and is based in Paris, France.
No recent news for this company.
No recent deals for this company.